Drug Type Small molecule drug |
Synonyms RGT 264, RGT-264, RGT264 |
Target |
Mechanism HPK1 inhibitors(Mitogen-activated protein kinase kinase kinase kinase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 1 | CN | Regor Therapeutics GroupStartup | 26 Apr 2023 |
Advanced Malignant Solid Neoplasm | Phase 1 | CN | 15 Feb 2023 |